Delivery Order SPE2DB20D7061-SPE2DB25FSLE8
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,798.85 firm-fixed-price delivery order is for the supply of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of febuxostat 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a completion date of March 18, 2025. The contract has a ceiling value of $1,245.38 and is a firm fixed-price delivery order. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,021.11 firm fixed-price delivery order is for the supply of 4,566,211,033 tablets of febuxostat 40 mg, a medication used to treat gout. The contract has an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,116.62 firm fixed-price delivery order is for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.73, is a Firm Fixed Price Delivery Order for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,872.04 firm fixed-price delivery order is for the supply of febuxostat 80 mg tablets, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of febuxostat 40 mg tablets, a medication used for the treatment of gout. The delivery order has a ceiling value of $3,060.37 and is a Firm Fixed Price contract. The period of performance runs through December 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $20,330.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, valued at $1,774.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567999145 - FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. This is a firm fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not set aside and is open to full and open competition....